{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:58:36Z","timestamp":1785466716327,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12328-026-02359-4","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:35:42Z","timestamp":1779107742000},"page":"950-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of long-term survival in unresectable pancreatic cancer with BRCA germline mutation treated with platinum-based chemotherapy"],"prefix":"10.1007","volume":"19","author":[{"given":"Keita","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Yamao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Sako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-4618","authenticated-orcid":false,"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2359_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","volume":"10","author":"AL Blackford","year":"2024","unstructured":"Blackford AL, Canto MI, Dbouk M, et al. Pancreatic cancer surveillance and survival of high-risk individuals. JAMA Oncol. 2024;10:1087\u201396.","journal-title":"JAMA Oncol"},{"key":"2359_CR2","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2359_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817\u201325.","journal-title":"N Engl J Med"},{"key":"2359_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"2359_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4166\/kjg.2023.140","volume":"83","author":"YJ Song","year":"2024","unstructured":"Song YJ, Choi JH. Long-term survivor of unresectable pancreatic cancer treated with concurrent chemoradiotherapy. Korean J Gastroenterol. 2024;83:28\u201332.","journal-title":"Korean J Gastroenterol"},{"key":"2359_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241274559","volume":"31","author":"LT Wang","year":"2024","unstructured":"Wang LT, Yang J, Wu J, et al. Combined therapy of chemotherapy and radiofrequency ablation for pancreatic cancer patients with metachronous hepatic metastatic lesions after radical pancreatic resection. Cancer Control. 2024;31:10732748241274559.","journal-title":"Cancer Control"},{"key":"2359_CR7","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.3748\/wjg.v21.i48.13574","volume":"21","author":"SY Oh","year":"2015","unstructured":"Oh SY, Edwards A, Mandelson MT, et al. Rare long-term survivors of pancreatic adenocarcinoma without curative resection. World J Gastroenterol. 2015;21:13574\u201381.","journal-title":"World J Gastroenterol"},{"key":"2359_CR8","first-page":"49","volume":"31","author":"E Aksoy","year":"2015","unstructured":"Aksoy E, Ula\u015f M, \u00c7olako\u011flu MK, et al. Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy. Ulus Cerrahi Derg. 2015;31:49\u201351.","journal-title":"Ulus Cerrahi Derg"},{"key":"2359_CR9","first-page":"208","volume":"3","author":"BM Chue","year":"2009","unstructured":"Chue BM. Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope. Gastrointest Cancer Res. 2009;3:208\u201311.","journal-title":"Gastrointest Cancer Res"},{"key":"2359_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/PPO.0b013e318278c4a6","volume":"18","author":"S Solomon","year":"2012","unstructured":"Solomon S, Das S, Brand R, et al. Inherited pancreatic cancer syndromes. Cancer J. 2012;18:485\u201391.","journal-title":"Cancer J"},{"key":"2359_CR11","first-page":"2413","volume":"35","author":"M Hirota","year":"2008","unstructured":"Hirota M, Yagi Y, Yamashita K, et al. (2008) [A long survival case of unresectable pancreatic cancer by chemoradiotherapy with gemcitabine as key drug]. Gan Kagaku Ryoho Cancer Chemother. 2008;35:2413\u20136.","journal-title":"Gan Kagaku Ryoho Cancer Chemother"},{"key":"2359_CR12","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.21037\/jgo-23-655","volume":"14","author":"S Satoi","year":"2023","unstructured":"Satoi S, Yamamoto T, Hashimoto D, et al. Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study. J Gastrointes Oncol. 2023;14:2587\u201399.","journal-title":"J Gastrointes Oncol"},{"key":"2359_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238395","author":"PT Shelemey","year":"2021","unstructured":"Shelemey PT, Amaro CP, Ng D, et al. Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment. BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2020-238395.","journal-title":"BMJ Case Rep"},{"key":"2359_CR14","volume":"2015","author":"C Nikolaou","year":"2015","unstructured":"Nikolaou C, Matikas A, Papavasilopoulou M, et al. Prolonged complete response in a patient with metastatic pancreatic adenocarcinoma after FOLFIRINOX chemotherapy and maintenance with FOLFIRI. Case Rep Oncol Med. 2015;2015:659624.","journal-title":"Case Rep Oncol Med"},{"key":"2359_CR15","doi-asserted-by":"publisher","first-page":"5832309","DOI":"10.1155\/2019\/5832309","volume":"2019","author":"C Franck","year":"2019","unstructured":"Franck C, Canbay A, Malfertheiner P, et al. Maintenance therapy with FOLFIRI after FOLFIRINOX for advanced pancreatic ductal adenocarcinoma: a retrospective single-center analysis. J Oncol. 2019;2019:5832309.","journal-title":"J Oncol"},{"key":"2359_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M, et al. Maintenance Olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381:317\u201327.","journal-title":"N Engl J Med"},{"key":"2359_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.pan.2022.05.004","volume":"22","author":"H Sato","year":"2022","unstructured":"Sato H, Yoshida R, Yasui K, et al. Feasibility of local therapy for recurrent pancreatic cancer. Pancreatology. 2022;22:774\u201381.","journal-title":"Pancreatology"},{"key":"2359_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-021-01236-w","volume":"21","author":"T Mashiko","year":"2021","unstructured":"Mashiko T, Nakano A, Masuoka Y, et al. Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study. BMC Surg. 2021;21:237.","journal-title":"BMC Surg"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02359-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:04:38Z","timestamp":1785463478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02359-4","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the institutional review board because this study was a single case report.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}